Nucleoside analogues have been the cornerstone of antiviral therapy over th
e past thirty years and, currently, 16 commonly used antiviral drugs belong
to this category. Although for long time it was believed that only D-nucle
osides, possessing a 'natural' stereochemistry, could elicit biological act
ivity, in the last decade this has been proven not to be true. 3TC, a L-nuc
leoside analogue, is one of the most effective anti-HIV and anti-hepatitis
B virus drugs, and nine other L-nucleosides are currently undergoing clinic
al trials and/or preclinical studies as antiviral or antitumoral agents. Th
is minireview summarizes some biological features and the current status of
these promising L-nucleoside analogues. (C) 2001 Federation of European Mi
crobiological Societies. Published by Elsevier Science B.V. All rights rese
rved.